“Treating Spinal Muscular Atrophy (SMA) in the Womb: Early Evidence for Prenatal Risdiplam Therapy”
Written and Reviewed By: Vikas Londhe (M.Pharm, Pharmacology) Source: Freepik.com Spinal muscular atrophy (SMA) is a rare but serious genetic neuromuscular disorder characterized by the degeneration of mot ...
“Saarvienin A: A Novel Antibiotic from Rare Earth Mine in China Targets Vancomycin-Resistant Gram-Positive Bacteria”
Written by: Utkarsha Patil (M.Pharm, Pharmacology) Source: Freepik.com The growing threat of antimicrobial resistance (AMR) strengthens the urgent need to search for novel therapeutic agents. Amid this grow ...
Beyond Weight Loss: First-Generation GLP-1 Drugs Like Liraglutide and Exenatide Show Promising Anti-Cancer Effects
Written By: Smaiksha Benke, M.Pharm Pharmacology Source: Freepik.com Obesity is a major global health concern and a known risk factor for at least 13 different types of cancer. The increasing prevalence of ...
“The Curious Case of KJ: How the World’s First CRISPR-Cas9 Gene Editing Therapy Saved a Child from Fatal CPS1 Deficiency”
Written by: Shital Gaikwad M.Pharm (Pharmacology) Source: Freepik.com In a landmark medical breakthrough, a young child identified only as KJ became the first known patient to be successfully treated for a ...
“Teal Wand Becomes First FDA Approved At Home Cervical Cancer Screening Device for High-Risk HPV – A Breakthrough for Women’s Health”
Written by: Priya Bhaware M.Pharm (Pharmacology) Source: Freepik.com On May 9, 2025, the U.S. Food and Drug Administration (FDA) approved the Teal Wand medical device. Teal Health, the first FDA-authorized ...
NEJM Commentary: FDA Says Updated Evidence-Based COVID-19 Vaccine Policy Represents the Scientific Gold Standard
Written by Rikesh Dhanraj Dighore (M.Pharm Pharmacology) "The FDA's new Covid-19 philosophy represents a balance of regulatory flexibility and a commitment to gold-standard science (Source: Freepik.com) On ...
“England Rolls Out 5-Minute Subcutaneous Opdivo (Nivolumab) for 15+ Cancer Types, Enhancing Treatment Speed and Patient Convenience”
Written by Priyanka Khamkar (M. Pharm) Pharmacology and Vikas Londhe M.Pharm, Pharmacology Source: Freepik.com The UK's National Health Service (NHS) has rolled out Opdivo, an immunotherapy drug in a 3-5 mi ...
Tepezza (Teprotumumab) A first Targeted Drug Receives Positive CHMP Opinion from EMA and Approval from MHRA to Treat Moderate to Severe Thyroid Eye Disease (TED) by Targeting IGF-1 Receptor
Written by: Shakuntala Kawhale (Pharmacology), Utkarsha Patil (Pharmacology) and Shital Gaikwad (Pharmacology) Source: Freepik.com The European Medicines Agency’s (EMA) Committee for Medicinal Products for ...
Qoyvolma: A More Affordable Biologic Option for Plaque Psoriasis and Inflammatory Diseases like Psoriatic Arthritis, Cohn’s Disease, and Ulcerative Colitis
Written by Rikesh Dighore (Pharmacology) and Soniya Hajare (Pharmacology) Source: Freepik.com The European Medicines Agency’s (EMA) Committee for Medicinal Product for Human Use (CHMP) has accepted a positi ...
EMA’s CHMP Recommends Sephience (sepiapterin) for Hyperphenylalaninaemia (HPA) in Adults and Children with Phenylketonuria (PKU)
Written by: Priya Bhaware M.Pharm (Pharmacology) and Samiksha Benke M.Pharm (Pharmacology) In image the newborn baby's heel is being prepared for Guthrie Test to detect Phenylketonuria (Source: Freepik.com) ...